GS-9973

Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia
Yahoo/BusinessWire
Sun, 12/8/13 - 12:03 pm
chronic lymphocytic leukemia
GS-9973
Gilead Sciences